Genes in MS Patients Schenectady NY

Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports. "Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release.

Local Companies

Diane A Bourke
(518) 262-6317
389 Myrtle Avenue
Albany, NY
Robert W. Kipp
518-477-5000
568 Columbia Tpke. 
East Greenbush, NY
Bradley J Elliott
518-383-4889
677 Plank Rd. 
Clifton Park, NY
Paul F Lewandowski
518-399-2225
802 Route 50 
Burnt Hills, NY
Phyllis M DellaCroce
518-664-3961
505 Park Ave. 
Mechanicville, NY
Malta Animal Hospital
(518) 885-2550
604 State Route 67
Malta, NY
Charmaine A Martin, MD
(518) 382-2260
624 McClellan St
Schenectady, NY
Dr. Mike Wayne
518-371-4800
2 Emma Lane
Clifton Park, NY
The Animal Hospital PC
(518) 456-0852
2 Rocking Horse Lane
Guilderland, NY
Ronald G Rayher
518-383-3700
865 Route 146 
Clifton Park, NY
Data Provided by:
  

Provided By:

FRIDAY, Sept. 11 (HealthDay News) -- Two genes in mice have been linked to improvements in the body's ability to repair itself when afflicted with multiple sclerosis, potentially leading to more effective treatments, a U.S. scientist reports.

"Most MS genetic studies have looked at disease susceptibility -- or why some people get MS and others do not," study author Allan Bieber, a Mayo Clinic neuroscientist, said in a Mayo news release. "This study asked, among those who have MS, why do some do well with the disease while others do poorly, and what might be the genetic determinants of this difference in outcome."

The study, which was scheduled to be presented Friday at the Congress of the European Committee for Treatment and Research in Multiple Sclerosis in Dusseldorf, Germany, identified two genes that appear to lead to repair of damage caused by multiple sclerosis in mice.

Multiple sclerosis affects about 330,000 people in the United States. The disease targets the central nervous system and damages the insulation that covers nerves. People with the disease suffer from a variety of symptoms, including loss of strength, vision, balance and muscle coordination.

"It's possible that the identification of these genes may provide the first important clue as to why some patients with MS do well, while others do not," Bieber said in the news release.

More information

Learn more about the disease from the National Multiple Sclerosis Society.

SOURCE: Mayo clinic, news release, Sept. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Genetic Clues for Skin Cancer Therapies Schenectady NY
Scientists have isolated a group of genetic mutations involved in the growth of melanoma, the deadliest form of skin cancer. Their work may lead to therapies with existing drugs that target the same mutations. Led by Yardena Samuels of the National Human Genome Research Institute, the research team from the U.S. National Institutes of Health (NIH) sequenced the protein tyrosine kinase (PTK) gene family in tumor and blood samples from people with metastatic melanoma.
- Gene Therapy for Parkinson's Schenectady NY
- Gene Variants and Alzheimer's Risk Schenectady NY
- Depression in Heart Disease Patients Schenectady NY
- Exercise for Chemotherapy Patients Schenectady NY
- Side Effect Of Chemotherapy Drugs Schenectady NY
- High Blood Pressure Genes Schenectady NY
- Differences Between Hospice and Palliative Care Schenectady NY
- Doctor-Patient Talk for Hypertension Schenectady NY
- Hospice: Getting Back Control of Your Life Schenectady NY